FERRIC CITRATE: AN IRON-BASED ORAL PHOSPHATE BINDER
Patients with end-stage renal disease (ESRD) often experience secondary bone and mineral disorder requiring treatment with phosphate-binder (PB) medications, vitamin D sterols, and calcimimetics. Ferric citrate is an oral, iron-based PB in clinical development that has been shown to reduce serum pho...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
The Korean Society of Nephrology,
2012-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|